We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
- Authors
Dixon, Bradley S; Beck, Gerald J; Dember, Laura M; Depner, Thomas A; Gassman, Jennifer J; Greene, Tom; Himmelfarb, Jonathan; Hunsicker, Lawrence G; Kaufman, James S; Lawson, Jeffrey H; Meyers, Catherine M; Middleton, John P; Radeva, Milena; Schwab, Steve J; Whiting, James F; Feldman, Harold I; DAC Study Group
- Abstract
Surgically created arteriovenous (AV) grafts are the most common type of hemodialysis vascular access in the United States, but fail frequently due to the development of venous stenosis. The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts.
- Publication
Clinical trials (London, England), 2005, Vol 2, Issue 5, p400
- ISSN
1740-7745
- Publication type
Journal Article
- DOI
10.1191/1740774505cn110oa